Original contribution
The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 1251 implantation

https://doi.org/10.1016/0360-3016(91)90668-TGet rights and content

Abstract

The study evaluates the effect of the locally recurring tumor on the incidence of metastatic disease in early stage carcinoma of the prostate. The probability of distant metastases was studied in 679 patients with Stage B-C/NO carcinoma of the prostate treated at MSKCC between 1970 and 1985 (median follow-up of 97 months). Patients were staged with pelvic lymph node dissection and treated with retropubic 125I implantation. The actuarial distant metastases free survival (DMFS) for patients at risk at 15 years after initial therapy was 37%. Cox proportional hazard regression analysis of covariates affecting the metastatic outcome showed that local failure, used in the model as a time dependent variable, was the most significant covariate, although stage, grade, and implant volume were also found to be independent variables. The relative risk of metastatic spread subsequent to local failure was 4-fold increased compared to the risk without evidence of local relapse. The 15-year actuarial DMFS in 351 patients with local control was 77% compared to 24% in 328 patients who developed local relapses (p < 0.00001). The relation of distant spread to the local outcome was observed regardless of stage, grade, or implant dose. Even stage BI/NO-Grade I patient with local control showed a 15-year actuarial DMFS of 82%, compared to 22% in patients with local relapse; p < 0.00001). The median local relapse-free survival (LRFS) in the 268 patients with local recurrences who did not receive hormonal therapy before distant metastases were detected was 51 months, compared to a median of 71 months for DMFS in the same patients (p < 0.001), consistent with the possibility that distant dissemination may develop secondary to local failure. Furthermore, distant metastases in patients with local control, apparently already existing as micrometastases before treatment, were detected earlier (median DMFS of 37 months) than in patients with local relapse (median DMFS of 54 months; p = 0.009). These data suggest that the existence and re-growth of local residual disease in localized prostatic carcinoma promotes an enhanced spread of metastatic disease, and that early and complete eradication of the primary tumor is required if a long term cure is to be achieved, although the clinical expression of secondary metastases may not become apparent for 6.5 years or more in one-half of the patients.

References (60)

  • P.H. Lange et al.

    Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results

    J. Urol.

    (1986)
  • D.F. Paulson et al.

    Radical prostatectomy for clinical stage T1-2NOMO prostatic adenocarcinoma: long-term results

    J. Urol.

    (1990)
  • C.A. Perez et al.

    Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis

    Int. J. Radiat. Oncol. Biol. Phys.

    (1980)
  • M.V. Pilepich et al.

    Postoperative irradiation in carcinoma of the prostate

    Int. J. Radiat. Oncol. Biol. Phys.

    (1984)
  • G.R. Ray et al.

    External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy

    J. Urol.

    (1984)
  • P.T. Scardino et al.

    Staging of prostate cancer. Advances in urologic ultrasound

    Urol. Clin. North Am.

    (1989)
  • W.G.J.M. Smit et al.

    Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose

    Int. J. Radiat. Oncol. Biol. Phys.

    (1990)
  • R.K. Ten Haken et al.

    Boost treatment of the prostate using shaped, fixed fields

    Int. J. Radiat. Oncol. Biol. Phys.

    (1989)
  • A. Villers et al.

    The role of perineural space invasion in the local spread of prostatic adenocarcinoma

    J. Urol.

    (1989)
  • P.C. Walsh

    Adjuvant radiotherapy after radical prostatectomy: is it indicated?

    J. Urol.

    (1987)
  • W.F. Whitmore et al.

    Retropubic implantation of iodine 125 in the treatment of prostatic cancer

    J. Urol.

    (1972)
  • W.F. Whitmore et al.

    Implantation of 125I in prostatic cancer

    Sur. Clinics of N. America

    (1974)
  • L.L. Anderson

    Spacing nomograph for interstitial implant of interstitial implant of 1251 seeds

    Med. Phys.

    (1976)
  • L.L. Anderson et al.

    Computerized dosimetry for 1251 prostate implants

  • M.A. Batata et al.

    Factors affecting tumor control

  • J. Berkson et al.

    Calculations of survival rates for cancer

  • W.J. Catalona et al.

    Nerve-sparing radical prostatectomy: evaluation of results after 250 patients

    J. Urol.

    (1990)
  • D.R. Cox

    Regression models and life tables

    J. Roy. Statist. Soc.

    (1972)
  • O.S. Culp

    Radical perineal prostatectomy: its past, present and possible future

    J. Urol.

    (1968)
  • J.E. Fowler et al.

    The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer

    Cancer

    (1981)
  • Cited by (0)

    Current address: New York Medical College, Westchester, New York.

    View full text